Aspiriant LLC’s Perceptron Inc PRCP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-15,182
| Closed | -$103K | – | 226 |
|
|
2020
Q3 | $103K | Buy |
15,182
+1,115
| +8% | +$4.83K | 0.01% | 214 |
|
|
2020
Q2 | $47K | Buy |
14,067
+981
| +7% | +$2.88K | ﹤0.01% | 182 |
|
|
2020
Q1 | $38K | Buy |
13,086
+667
| +5% | +$3.29K | ﹤0.01% | 184 |
|
|
2019
Q4 | $68K | Hold |
12,419
| – | – | 0.01% | 201 |
|
|
2019
Q3 | $60K | Buy |
12,419
+847
| +7% | +$3.81K | 0.01% | 212 |
|
|
2019
Q2 | $51K | Buy |
11,572
+1,429
| +14% | +$8.46K | ﹤0.01% | 228 |
|
|
2019
Q1 | $76K | Hold |
10,143
| – | – | 0.01% | 228 |
|
|
2018
Q4 | $82K | Hold |
10,143
| – | – | 0.01% | 223 |
|
|
2018
Q3 | $99K | Hold |
10,143
| – | – | 0.01% | 238 |
|
|
2018
Q2 | $107K | Hold |
10,143
| – | – | 0.01% | 242 |
|
|
2018
Q1 | $89K | Hold |
10,143
| – | – | 0.01% | 237 |
|
|
2017
Q4 | $99K | Buy |
+10,143
| New | +$91.4K | 0.03% | 82 |
|
Aspiriant LLC's PRCP Position: Q4 2020 in Review
Aspiriant LLC sold out of Perceptron Inc (PRCP) in Q4 2020, closing a stake of 15,182 shares — an estimated $103K sold.
Aspiriant LLC first reported a position in PRCP in Q4 2017 and held it in 12 quarters. The position peaked at $107K in Q2 2018. 1 fund tracked by Wall St. Rank holds PRCP as of Q4 2020.
- Aspiriant LLC reported no remaining Perceptron Inc position as of Q4 2020 after selling out during the quarter.
- Aspiriant LLC sold 15,182 Perceptron Inc shares in Q4 2020, an estimated $103K.
- Aspiriant LLC first reported a position in Perceptron Inc in Q4 2017 and held it in 12 quarters.
- Aspiriant LLC's Perceptron Inc position peaked at $107K in Q2 2018.
- 1 fund tracked by Wall St. Rank held Perceptron Inc as of Q4 2020.
Based on Aspiriant LLC's 13F filing for Q4 2020, filed 1 Feb 2021.